Skip to main content
Industry News
Liver cancer risk in HBV similar for tenofovir, entecavir

A meta-analysis study reported in The Lancet Gastroenterology & Hepatology found liver cancer risks were similar for patients with chronic hepatitis B whether they take tenofovir or entecavir. Researchers reviewed literature from 2006 to 2020, 2018 and 2019 conference abstracts, and 31 studies that included more than 119,000 patients with chronic hepatitis B.

Full Story: